DTP-HepB-IPV-Hib vaccine - LG Chem
Alternative Names: APV-006; Diphtheria-Tetanus-Pertussis-Hepatitis B-Inactivated Poliovirus-Haemophilus influenzae type b vaccine; DTwP-HepB-IPV-Hib vaccineLatest Information Update: 25 Jul 2023
At a glance
- Originator LG Chem
- Class Bacterial vaccines; Haemophilus vaccines; Hepatitis B vaccines; Viral hepatitis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
Most Recent Events
- 19 Jul 2023 LG Chem plans a phase I trial for Healthy volunteers (In Adults) (NCT05952596)
- 19 Jul 2022 LG Chem plans a phase II/III trial for Diphtheria, Haemophilus infections, Hepatitis B, Pertussis, Poliomyelitis, Tetanus (In infants, Prevention) in February 2023 (IM, Injection) (NCT05457946)
- 22 Jan 2021 Phase-II clinical trials in Diphtheria (Prevention) in South Korea (Parenteral)